Copy
View this email in your browser
COVID-19 Update
December 21, 2020
IowaBio wants to provide our members useful information during the COVID-19 pandemic. This newsletter compiles information on state, federal and industry action to combat the virus and its impacts.

If your company is helping respond to COVID-19, IowaBio wants to know about it. Please, send any information about what your biotechnology company or organization is doing to help, to Jessica Hyland at Jessica@iowabio.org.

If IowaBio can assist you in getting information out, connecting with public officials, or support your company in another way, please do not hesitate to reach out.

Past IowaBio COVID-19 Update newsletters are now available at www.iowabio.org/COVID19 and can be found under the Industry News tab on the IowaBio website.

COVID-19 Vaccine Update

On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older. Distribution of the vaccine will begin today.

Already, more than 556,000 doses of the Pfizer/BioNTech vaccine have been administered, according to the US Centers for Disease Control and Prevention, and 2.8 million doses have been distributed.
IDPH Expected Approximate Vaccine Allocation as of 12.17.18, for Planning Purposes Only. These numbers are subject to change:
Allocation Date
12/13/20
12/20/20
12/27/20
Total
Pfizer
26,000
19,500
19,500
65,000
Moderna
0
53,800
19,500
73,300
Total
26,000
73,300
39,000
138,300
ACIP recommended yesterday that those over 75 and critical workers should be prioritized next in the vaccine rollout, to prevent mortality and preserve societal functioning.

Key Statistics

Iowa
Currently, IDPH has reported on the state’s coronavirus dashboard, 267,726 Iowans have tested positive, up 3,621 from our update Friday morning, with a total of 1,317,908 tested. 138 additional deaths were reported since our last update, bringing the total to 3,589 deaths. Now 208,681 Iowans have recovered. The total 14 day rolling average positivity rate is 13.1% the past 7-day average is 10.2%. The latest on hospitalizations, including how many patients have been admitted in the last 24 hours can be found here. There are currently 644 hospitalized patients.
 
School district statistics including positivity rates by county can be found here. According to guidance issued by the Iowa Department of Education, schools may petition to go to hybrid or online learning with less than 50 percent in-person instruction when the per county percentage positivity rates are above 15 percent in a county on average over the past 14 days (rolling average) AND 10% absenteeism among students is expected for in-person learning. School district waiver requests and whether they are granted or denied are listed here.
 
Currently 28 (of 99) counties are above a 15 percent positivity rate over the past 14 days. Click here to search county data for today.
 
US
Total Cases 17,592,760
Total Deaths 315,260

World
Total Cases 76,928.774
Total Deaths 1,695,307
 
BIO Pipeline Tracker
788 Unique compounds in development
194 vaccines
221 antivirals
373 treatments
Sincerely,
Jessica

Jessica Hyland, J.D.
Executive Director
Iowa Biotechnology Association
Cell: (515) 822-1315
Office: (515) 327-9156
Fax: (515) 327-1407
jessica@iowabio.org
www.iowabio.org
Twitter
Facebook
Website
Copyright © 2020 Iowa Biotechnology Association, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp